ENDEFR
Home › Luxembourg › AbbVie Investments S.à r.l.

AbbVie Investments S.à r.l.

Société à responsabilité limitée (SARL) · Luxembourg, Luxembourg · LEI 549300Z3UM6YGMP2QK35
LEI lapsed

Summary

AbbVie Investments S.à r.l. is registered in Luxembourg and entered in the “Trade and Companies Register (RCS)” under number B166925. Its legal form is Société à responsabilité limitée (SARL) – private limited company (Luxembourg). According to GLEIF, its ultimate parent is ABBVIE INC. (United States), which is also its direct parent. That group has 64 subsidiaries with LEIs in 37 countries, 4 of them in Luxembourg. The LEI was first issued on 5 Dec 2012 and the record was last updated on 16 Sep 2024. It has lapsed: renewal was due by 5 Apr 2022. AssetCensus found 3 data-quality notes for this entity (see below).

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

  • The LEI has lapsed: it was due for renewal by 5 Apr 2022 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
  • The ultimate-parent link rests on accounts for the period ending 31 Dec 2020, more than 24 months before this data release. The group may have changed since.
  • The ultimate-parent relationship record was not renewed; it was last updated on 10 Nov 2025.

Company details

Legal formSociété à responsabilité limitée (SARL)
private limited company (Luxembourg)
RegisterTrade and Companies Register (RCS) · Register website
Registration numberB166925
Registration authorityLuxembourg Business Registers
JurisdictionLuxembourg
Registered address26, Boulevard Royal, L-2449 Luxembourg, Luxembourg
Headquarters address1 North Waukegan Road, 60064 North Chicago, United States
Categorycompany or other legal entity
Statusactive
LEI549300Z3UM6YGMP2QK35
LEI statuslapsed
LEI first issued5 Dec 2012
LEI record last updated16 Sep 2024
Next LEI renewal5 Apr 2022
Corroboration of the LEI recordfully corroborated

Group membership

ABBVIE INC. United States ultimate parent
AbbVie Investments S.à r.l. this entity
View the whole group: 64 subsidiaries in 37 countries

Relationship to the parent

Direct parentUltimate parent
ParentABBVIE INC.ABBVIE INC.
Accounting period1 Jan 2020 to 31 Dec 20201 Jan 2020 to 31 Dec 2020
Evidenceother official documentsother official documents
Corroborationsupplied by the entity onlysupplied by the entity only
Relationship start20 Mar 201820 Mar 2018
Recorded at GLEIF since13 Sep 202113 Sep 2021
Last updated10 Nov 202510 Nov 2025
Record statusnot renewednot renewed

Other subsidiaries of the same direct parent (59)

and 47 more

Other names

  • WCA Pharmaceuticals Investments S.à r.l. · previous name